Clinical Trials

When Karuna’s KarXT won FDA approval last year, it validated a counterintuitive principle in drug development: sometimes the best way to make a drug work isn’t to change the drug itself—it’s to add a second one that blocks it everywhere except where you need it.  That insight, along with the journeys of two other 2024…